Rate these BOPA Podcast name suggestions
Thank you to everyone who submitted an idea for the BOPA podcast name. We received almost 50 suggestions! We have chosen our top 5 and now we are asking you…
Find out the latest with BOPA, Oncology, and upcoming events
Thank you to everyone who submitted an idea for the BOPA podcast name. We received almost 50 suggestions! We have chosen our top 5 and now we are asking you…
At the national Quality Assurance and Technical Services symposium on the 9th of November we announced the launch of an Expert Panel to provide the governance and assurance for the…
Last chance to contribute to the IV SACT survey. The deadline for completing the IV SACT survey has been extended until 9am on Monday 21st November. The initial results of…
In September, NICE updated its Systemic anti-cancer therapy (SACT) for advanced non small cell lung cancer: treatment options summary: https://www.nice.org.uk/guidance/ng122/resources/interactive-pdf-of-all-treatment-pathways-for-squamous-and-nonsquamous-advanced-nonsmallcell-lung-cancer-pdf-11189888174. The aim of this summary is to collate NICE technology…
The UK BMT Pharmacists’ Group (a special-interest group affiliated to BOPA) is running an educational meeting via Zoom on the afternoon of Friday 25th November. The meeting will run from…
The BOPA E&T committee and BOPA digital committee are working on a new BOPA Pod Cast for 2023! And we still need a name….. We only had a couple of…
‘A life in a day’ simulation experience: perceptions of oncology nurses and pharmacy staff Rachel Ehibhatiomhan, Emma Foreman, Lisa Barrott, Jessica Shek & Shereen Nabhani-Gebara Background Due to an increase…
The BOPA E&T Subcommittee would like to invite you to one of our live webinar sessions on “A Small Oncology Team in the Middle of the Atlantic Ocean”. Speaker: James…
I am pleased to inform you that the lung cancer SACT consent forms have been reviewed and updated. They are now available on the CRUK website at : www.cruk.org/sact_consent. …
In 2020, in response to the COVID pandemic and the impact on cancer care, BOPA produced a statement outlining recommendations for possible changes to both clinical and operational oncology pharmacy…
The BOPA E&T Subcommittee would like to invite you to one of our live webinar sessions on “Adjuvant Endocrine Therapy for Hormone Receptor Positive Breast Cancer from a dual perspective”. …
The results of the BOPA/Royal Marsden IV SACT survey were presented to the NHS Infusions and Special Medicines Board earlier in the month and generated a great deal of interest. …